226 related articles for article (PubMed ID: 11046091)
21. Elevated systemic levels of endothelin-1 and blood pressure correlate with blunted constrictor responses and downregulation of endothelin(A), but not endothelin(B), receptors in an animal model of hypertension.
Télémaque-Potts S; Kuc RE; Maguire JJ; Ohlstein E; Yanagisawa M; Davenport AP
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():357S-362S. PubMed ID: 12193122
[TBL] [Abstract][Full Text] [Related]
22. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation.
Kawamoto JH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Cardiovasc Pharmacol; 1990 May; 15(5):714-9. PubMed ID: 1692930
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde dehydrogenase, nitric oxide synthase and superoxide in ex vivo nitrate tolerance in rat aorta.
de la Lande IS; Stepien JM; Philpott AC; Hughes PA; Stafford I; Horowitz JD
Eur J Pharmacol; 2004 Aug; 496(1-3):141-9. PubMed ID: 15288585
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies.
Wessale JL; Adler AL; Novosad EI; Calzadilla SV; Dayton BD; Marsh KC; Winn M; Jae HS; von Geldern TW; Opgenorth TJ; Wu-Wong JR
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():112S-117S. PubMed ID: 12193067
[TBL] [Abstract][Full Text] [Related]
25. Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin.
Abou-Mohamed G; Johnson JA; Jin L; El-Remessy AB; Do K; Kaesemeyer WH; Caldwell RB; Caldwell RW
J Pharmacol Exp Ther; 2004 Jan; 308(1):289-99. PubMed ID: 14563789
[TBL] [Abstract][Full Text] [Related]
26. Effect of tolerance to glyceryl trinitrate on vascular responses in conscious rabbits.
Du ZY; Dusting GJ; Woodman OL
Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):439-47. PubMed ID: 1914247
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin regulates endothelin-B receptor in rat inner medullary collecting duct.
Wong NL; Tsui JK
Metabolism; 2001 Jun; 50(6):661-6. PubMed ID: 11398142
[TBL] [Abstract][Full Text] [Related]
28. Investigation of role for oxidant stress in vascular tolerance development to glyceryl trinitrate in vitro.
Laight DW; Carrier MJ; Anggård EE
Br J Pharmacol; 1997 Apr; 120(8):1477-82. PubMed ID: 9113368
[TBL] [Abstract][Full Text] [Related]
29. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
30. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.
Chen YR; Nie SD; Shan W; Jiang DJ; Shi RZ; Zhou Z; Guo R; Zhang Z; Li YJ
Eur J Pharmacol; 2007 Sep; 571(1):44-50. PubMed ID: 17585900
[TBL] [Abstract][Full Text] [Related]
31. Development of tolerance towards glyceryl trinitrate in vitro. Low concentration induced tolerance and changes in cyclic guanosine-3',5'-monophosphate metabolism.
Ahlner J; Andersson RG; Axelsson KL; Ekstam Ljusegren M
Arzneimittelforschung; 1987 Aug; 37(8):914-6. PubMed ID: 2823843
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of T-0201, a highly potent and orally active endothelin receptor antagonist.
Hoshino T; Yamauchi R; Kikkawa K; Yabana H; Murata S
J Pharmacol Exp Ther; 1998 Aug; 286(2):643-9. PubMed ID: 9694915
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the pharmacological actions of glyceryl trinitrate after the electroporetic delivery of a glutathione S-transferase inhibitor.
Simon WC; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1535-40. PubMed ID: 8968380
[TBL] [Abstract][Full Text] [Related]
34. Role of endogenous hydrogen peroxide in the development of nitrate tolerance.
Ghatta S; Hemmer RB; Uppala S; O'Rourke ST
Vascul Pharmacol; 2007 Apr; 46(4):247-52. PubMed ID: 17157562
[TBL] [Abstract][Full Text] [Related]
35. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate.
Sarr M; Lobysheva I; Diallo AS; Stoclet JC; Schini-Kerth VB; Muller B
Eur J Pharmacol; 2005 Apr; 513(1-2):119-23. PubMed ID: 15878716
[TBL] [Abstract][Full Text] [Related]
36. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance.
Dikalov S; Fink B; Skatchkov M; Stalleicken D; Bassenge E
J Pharmacol Exp Ther; 1998 Aug; 286(2):938-44. PubMed ID: 9694953
[TBL] [Abstract][Full Text] [Related]
37. Tissue levels of glyceryl trinitrate and cGMP after in vivo administration in rat, and the effect of tolerance development.
Torfgård K; Ahlner J; Axelsson KL; Norlander B; Bertler A
Can J Physiol Pharmacol; 1991 Sep; 69(9):1257-61. PubMed ID: 1661636
[TBL] [Abstract][Full Text] [Related]
38. Changes in aldehyde dehydrogenase 2 expression in rat blood vessels during glyceryl trinitrate tolerance development and reversal.
D'Souza Y; Dowlatshahi S; Bennett BM
Br J Pharmacol; 2011 Sep; 164(2b):632-43. PubMed ID: 21506955
[TBL] [Abstract][Full Text] [Related]
39. Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants.
Esplugues JV; Rocha M; Nuñez C; Bosca I; Ibiza S; Herance JR; Ortega A; Serrador JM; D'Ocon P; Victor VM
Circ Res; 2006 Nov; 99(10):1067-75. PubMed ID: 17053193
[TBL] [Abstract][Full Text] [Related]
40. Prevention of nitroglycerin tolerance in vitro by T0156, a selective phosphodiesterase type 5 inhibitor.
Liu CQ; Leung FP; Lee VW; Lau CW; Yao X; Lu L; Huang Y
Eur J Pharmacol; 2008 Aug; 590(1-3):250-4. PubMed ID: 18554583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
